NIH-funded research R21 grant

Menopause, Hormone Therapy, and HIV Risk in Cervical M mucosa

Official title: INVESTIGATING THE IMPACT OF MENOPAUSE AND MENOPAUSE HORMONE THERAPY ON IMMUNE DETERMINANTS OF HIV-1 SUSCEPTIBILTY IN CERVICAL MUCOSA

Funded at University of Alabama at Birmingham · NIH-11470603 · Data updated 2026-11-12

This project looks at how menopause and menopause hormone therapy may change the immune guard in the cervix, potentially affecting HIV risk for aging women.

More Menopause research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startJuly 22, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$223,500
NIH project number1R21AI203618-01
Project IDNIH-11470603 on NIH RePORTER

Who could benefit from this research

Could help

Women who are pre-, peri-, or menopausal and undergoing hysterectomy at UAB clinics, with or without menopause hormone therapy.

Less likely to help

Women not within the specified age/menopausal status or not undergoing hysterectomy at participating sites may not benefit.

What this research studies

Aging women are at rising risk for HIV, and menopause changes immune function. The study will use cervical tissue from women undergoing hysterectomies to examine how menopausal status and hormone therapy alter immune cells and pathways in cervicovaginal mucosa. Advanced techniques like high-parameter flow cytometry and single-cell RNA sequencing will map immune changes and how they relate to HIV susceptibility. The goal is to inform patients and healthcare providers about how menopause and hormone therapy could influence mucosal defense against infections.

Why it matters

Potential benefit: If successful, findings could guide safer menopause management and HIV prevention strategies for aging women.

How similar studies have gone: This approach uses established cervical tissue models and modern single-cell analyses, with some prior work in the field supporting mucosal immunology but combining them for menopause-related HIV susceptibility is novel.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Ochsenbauer, Christina — University of Alabama at Birmingham
  • Study coordinator: Ochsenbauer, Christina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.